Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarction

Clinical Genetics

Volumn 44, Issue 6, 1993, Pages 292-297

  Bohn M ^a   Berge, K E ^a   Bakken, A ^b   Erikssen, J ^c   Berg, K ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

angiotensin I converting enzyme; case control study; DNA; etiology; genetic markers; genetics; insertion deletion polymorphism; myocardial infarction; PCR; premature coronary heart disease

Indexed keywords

APOLIPOPROTEIN B; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; LIPID;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; HEART INFARCTION; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; BLOOD; CASE CONTROL STUDY; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; NORWAY; POLYMERASE CHAIN REACTION;

APOLIPOPROTEINS B; BODY MASS INDEX; CASE-CONTROL STUDIES; DNA; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; GENE FREQUENCY; GENOTYPE; HUMAN; LIPIDS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; NORWAY; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); RISK FACTORS; SEX FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0027787685     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1993.tb03903.x     Document Type: Article

References (35)

1. 1) angiotensin II receptor‐mediated stimulation of protein synthesis in chick heart cells
2. Twin studies of coronary heart disease and its risk factors
3. Genetics of atherosclerosis
4. Genetics of coronary heart disease and its risk factors
5. 1) locus on normal blood pressure level or variability
6. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability
7. Insertion deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and parental history of myocardial infarction
8. Deletion polymorphisin in the gene for angiotensin‐converting enzyme is a potent risk factor for myocardial infarction
9. Reversal of left ventricular hypertrophy in hypertensive patients: a metanalysis of 109 treatment studies
10. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge
11. Lipoproteins, cardiovascular disease, and death. The Framingham Study
12. Renin‐angiotensin system: a dual tissue and hormonal system for cardiovascular control
13. Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats
14. Cigarettes, coronary occlusions, and myocardial infarction
15. Cigarette smoking and risk of coronary heart disease. Epidemiological clues to pathogenesis. The Framingham study
16. Coronary heart disease in seven countries
17. Angiotensin and myocardial protein synthesis
18. Analysis of human Y‐chromosome‐specific reiterated DNA in chromosome variants
19. Genetics of essential hypertension
20. on behalf of the SAVE Investigators. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and the Ventricular Enlargement Trial
21. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems
22. An insertion/deletion polymorphism in the angiotensin I‐converting enzyme gene accounting for half the variance of serum enzyme levels
23. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
24. Enzymatische Bestimmung des Gesamt‐cholesterins im Serum
25. Two putative active centers in human angiotensin I‐converting enzyme revealed by molecular cloning
26. on behalf of the CONSENSUS II Study Group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
27. The SOLVD Investigators. Effect of Enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
28. Deletion polymorphism in angiotensin‐converting enzyme gene associated with parental history of myocardial infarction
29. A multivariate analysis of the risk of coronary heart disease in Framingham
30. Triglycerides. Determination after enzymatic hydrolysis
31. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin‐angiotensin‐aldosterone system
32. Multivariate analysis of risk factors for coronary heart disease
33. Effects of locally generated Angiotensin II on noradrenergic transmission in guinea‐pig isolated atria